These findings are also in keeping with recent experimental data suggesting a key role for Nox proteins in the progression of hepatic fibrosis [35] and for Nox2 in the modulation of inflammation in NAFLD [36]. This evidence concerns the gene CYBB and metabolic dysfunction-associated steatotic liver disease.